Driving discovery at Manchester Collaborative Centre for Inflammation Research
- Published: Thursday, 14 May 2015 11:13
- Written by National Centre for Universities and Business
Case study by Astrazeneca
The Manchester Collaborative Centre for Inflammation Research (MCCIR) is a unique, tripartite collaboration between the University of Manchester, AstraZeneca and GlaxoSmithKline (GSK). Each invested an equal amount to engage in pre-competitive research together.
MCCIR scientists aim to develop novel concepts in inflammation research that may lead to new discoveries for patients in an area of significant unmet clinical need. Inflammatory diseases affect millions of people worldwide, causing disability, pain and in some cases premature death. Inflammation is one of the body’s natural healing processes and understanding how and why inflammation becomes harmful is vital for improving treatment of chronic diseases such as respiratory diseases, cancer and heart disease.
“To our knowledge, this open innovation collaboration with academia and two industry partners contributing equally is unique. All credit to the University of Manchester for having the foresight and courage to undertake this venture. We now have greater opportunity to explore our innovative hypotheses and do cutting-edge science,” said Rose Maciewicz, Chief Scientist, Respiratory, Inflammation and Autoimmunity Innovative Medicines biotech unit, AstraZeneca. Edith M. Hessel, Vice President, Respiratory Therapy Area Unit, GSK, agreed, “MCCIR is pioneering a new approach to academic-industry collaboration that promises faster routes to scientific discovery, greater access to innovative projects and a new focus on finding treatments for the causes, rather than the outcomes, of inflammation.
“Brainstorming new concepts in inflammatory disease with industrial and clinical scientists and then having the freedom and the facilities to act upon these ideas is an unmissable opportunity. If our goal is to translate great basic science for the benefit of patients, then industrial scientists should be involved at the beginning of the discovery process. The MCCIR embodies a new model of partnership; a model that I believe will release the constraints on our understanding of inflammatory diseases and how to alleviate them,” said Professor Tracy Hussell, MCCIR Centre Director.
The collaboration has already brought tangible scientific results in several areas:
EDF Energy and the EDF group have been working in partnership with the University of Manchester to support resilient and cost effect nuclear energy.
Grafine Ltd will be based at the University of Manchester’s Innovation Centre and use the University’s world-class facilities for its product development work.
The University has recognised FinTech as a transformative sector. But what is FinTech and why do academics collaborate with business and vice versa?
An ultralight high-performance mechanical watch made with graphene was unveiled thanks to a unique collaboration.
Beijing Institute of Aeronautical Materials (BIAM) and the National Graphene Institute (NGI) at The University of Manchester will carry out a five-year collaborative research project.
The Manchester Collaborative Centre for Inflammation Research is a unique collaboration between the University of Manchester, AstraZeneca and GlaxoSmithKline.
The N8 Industry Innovation Forum leads the industry-facing activities of a collaboration of the 8 most research-intensive universities in the North of England.
The University of Manchester worked with EDF Energy to assess new environmentally friendly oils for use in power transformers.
A longstanding collaboration enables cutting-edge maths research to power the Numerical Algorithms Group's commercial software solutions.
James Baker from the National Graphene Institute says ‘graphene city’ can be a model for commercialising science.
Over six years helping to ensure the company has the technical capability and strong leadership to stay at the leading edge of its field.
Businesses are realising that universities are now much more ‘savvy’ and attuned to business needs